Clinical Trial Update: A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing posaconazole with voriconazole for invasive aspergillosis is completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infections
• Invasive Pulmonary Aspergillosis

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)
• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Fungal Infections, Invasive Pulmonary Aspergillosis | Phase 3 | Status: COMPLETED | Results posted: 2020-08-21